{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:48:30Z","timestamp":1784735310374,"version":"3.55.0"},"reference-count":196,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["1983 4\/1"],"award-info":[{"award-number":["1983 4\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Primary sclerosing cholangitis (PSC) is an immune-related cholangiopathy characterized by biliary inflammation, cholestasis, and multifocal bile duct strictures. It is associated with high rates of progression to end-stage liver disease as well as a significant risk of cholangiocarcinoma (CCA), gallbladder cancer, and colorectal carcinoma. Currently, no effective medical treatment with an impact on the overall survival is available, and liver transplantation is the only curative treatment option. Emerging evidence indicates that gut microbiota is associated with disease pathogenesis. Several studies analyzing fecal and mucosal samples demonstrate a distinct gut microbiome in individuals with PSC compared to healthy controls and individuals with inflammatory bowel disease (IBD) without PSC. Experimental mouse and observational human data suggest that a diverse set of microbial functions may be relevant, including microbial metabolites and bacterial processing of pharmacological agents, bile acids, or dietary compounds, altogether driving the intrahepatic inflammation. Despite critical progress in this field over the past years, further functional characterization of the role of the microbiota in PSC and related malignancies is needed. In this review, we discuss the available data on the role of the gut microbiome and elucidate important insights into underlying pathogenic mechanisms and possible microbe-altering interventions.<\/jats:p>","DOI":"10.3390\/ijms22136975","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T13:39:22Z","timestamp":1624887562000},"page":"6975","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-737X","authenticated-orcid":false,"given":"Burcin","family":"\u00d6zdirik","sequence":"first","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3426-5421","authenticated-orcid":false,"given":"Tobias","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wree","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sigal","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary Sclerosing Cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014A comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.hpb.2018.03.013","article-title":"Waitlist mortality and post-transplant survival in patients with cholestatic liver disease\u2014Impact of changes in allocation policy","volume":"20","author":"Staufer","year":"2018","journal-title":"HPB"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"ref_9","first-page":"124","article-title":"Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: An update of the evidence","volume":"32","author":"Mertz","year":"2019","journal-title":"Ann. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis","volume":"50","author":"Liwinski","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"Janse","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC Phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","article-title":"Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon","volume":"16","author":"Cleveland","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2010.223263","article-title":"Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives","volume":"60","author":"Joossens","year":"2011","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC\u2013IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis","volume":"10","author":"Kevans","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The Cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The Treatment-Naive Microbiome in New-Onset Crohn\u2019s Disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3350\/cmh.2012.18.4.337","article-title":"The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension","volume":"18","author":"Seo","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: Crosstalk between the liver and gut","volume":"590","author":"Seki","year":"2012","journal-title":"J. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"037","DOI":"10.1055\/s-0035-1571276","article-title":"Targeting Dysbiosis for the Treatment of Liver Disease","volume":"36","author":"Anand","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840130425","article-title":"Biliary tract disease in rats with experimental small bowel bacterial overgrowth","volume":"13","author":"Lichtman","year":"1991","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI115996","article-title":"Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth","volume":"90","author":"Lichtman","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary Sclerosing Cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0016-5085(91)90224-9","article-title":"Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline","volume":"100","author":"Lichtman","year":"1991","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/liv.13979","article-title":"Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis","volume":"39","author":"Dhillon","year":"2018","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","article-title":"Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis","volume":"40","author":"Cederborg","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic Endothelial CCL25 Mediates the Recruitment of CCR9+ Gut-homing Lymphocytes to the Liver in Primary Sclerosing Cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human -tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2009","journal-title":"Gut"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cgh.2019.05.013","article-title":"Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases","volume":"18","author":"Lynch","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MPG.0000000000002855","article-title":"Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium","volume":"71","author":"Laborda","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41575-018-0003-z","article-title":"Urbanization and the gut microbiota in health and inflammatory bowel disease","volume":"15","author":"Zuo","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nm.4185","article-title":"Signals from the gut microbiota to distant organs in physiology and disease","volume":"22","author":"Schroeder","year":"2016","journal-title":"Nat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: A review","volume":"26","author":"Little","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/apt.12663","article-title":"Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis","volume":"39","author":"Rupp","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cgh.2015.07.014","article-title":"Inflammation But Not Biliary Obstruction Is Associated with Carbohydrate Antigen 19-9 Levels in Patients with Primary Sclerosing Cholangitis","volume":"13","author":"Wannhoff","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1053\/j.gastro.2019.10.012","article-title":"A Mechanistic Insight Into the Role of Gut Microbiota in the Pathogenesis of Primary Sclerosing Cholangitis","volume":"157","author":"Patel","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0037-1608801","article-title":"The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts","volume":"37","author":"Hov","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/gutjnl-2016-312533","article-title":"Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis","volume":"66","author":"Iwasawa","year":"2016","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","article-title":"Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis","volume":"160","author":"Kummen","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II","volume":"9","author":"Rossen","year":"2015","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.13552","article-title":"The features of mucosa-associated microbiota in primary sclerosing cholangitis","volume":"43","author":"Torres","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"Heinsen","year":"2017","journal-title":"Gut"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","article-title":"Fungal dysbiosis in cirrhosis","volume":"67","author":"Bajaj","year":"2017","journal-title":"Gut"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2015.12.002","article-title":"Gut\u2013liver immunity","volume":"64","author":"Trivedi","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"The UniProt Consortium (2021). UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res., 49, D480\u2013D489.","DOI":"10.1093\/nar\/gkaa1100"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI73722","article-title":"Vascular adehesion protein 1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","author":"Weston","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Fodor, A.A., Klem, E.R., Gilpin, D., Elborn, J., Boucher, R.C., Tunney, M., and Wolfgang, M.C. (2012). The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045001"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/rccm.201403-0541OC","article-title":"The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis","volume":"190","author":"Molyneaux","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_74","first-page":"268","article-title":"Association between specific mucosa-associated microbiota in Crohn\u2019s disease at the time of resection and subsequent disease recurrence: A pilot study","volume":"30","author":"Kang","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn\u2019s disease: A multicentre inception cohort study","volume":"389","author":"Kugathasan","year":"2017","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4357","article-title":"Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis","volume":"23","author":"Worthmann","year":"2017","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1099\/ijs.0.000109","article-title":"Parabacteroides faecis sp. nov., isolated from human faeces","volume":"65","author":"Sakamoto","year":"2015","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/1574-6976.12075","article-title":"The first 1000 cultured species of the human gastrointestinal microbiota","volume":"38","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11745-006-5038-1","article-title":"Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria","volume":"41","author":"Narushima","year":"2006","journal-title":"Lipids"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapediatrics.2014.696","article-title":"Changes in gastric and lung microflora with acid suppression: Acid suppression and bacterial growth","volume":"168","author":"Rosen","year":"2014","journal-title":"JAMA Pediatr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1099\/jmm.0.008706-0","article-title":"Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis","volume":"58","author":"Oztas","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1099\/jmm.0.002188-0","article-title":"Liver cirrhosis caused by Exophiala dermatitidis","volume":"58","author":"Hong","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in IBD","volume":"66","author":"Sokol","year":"2016","journal-title":"Gut"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1099\/00221287-143-2-505","article-title":"Distribution of amine oxidases and amine dehydrogenases in bacteria grown on primary amines and characterization of the amine oxidase from Klebsiella oxytoca","volume":"143","author":"Hacisalihoglu","year":"1997","journal-title":"Microbiology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AEM.02340-06","article-title":"Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces","volume":"73","author":"Duncan","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1079\/PNS2003208","article-title":"Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes","volume":"62","author":"Pouteau","year":"2003","journal-title":"Proc. Nutr. Soc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Venegas","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cei.13397","article-title":"Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease","volume":"199","author":"Quraishi","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gutjnl-2016-312354","article-title":"Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner","volume":"67","author":"Trivedi","year":"2018","journal-title":"Gut"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Pereira, P., Aho, V., Arola, J., Boyd, S., Jokelainen, K., Paulin, L., Auvinen, P., and F\u00e4rkkil\u00e4, M. (2017). Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182924"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1053\/j.gastro.2016.12.048","article-title":"Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction","volume":"152","author":"Bouter","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal Virome in Patients with Alcoholic Hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00042737-200206000-00009","article-title":"A survey of infectious agents as risk factors for primary sclerosing cholangitis: Are Chlamydia species involved?","volume":"14","author":"Ponsioen","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1478-3231.2008.01851.x","article-title":"Occult hepatitis B virus infection in patients with autoimmune liver diseases","volume":"29","author":"Georgiadou","year":"2009","journal-title":"Liver Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000084605","article-title":"Primary Sclerosing Cholangitis and Hepatitis C Virus Infection","volume":"48","author":"Kim","year":"2005","journal-title":"Intervirology"},{"key":"ref_105","first-page":"39","article-title":"Small Duct Primary Sclerosing Cholangitis in Association With Hepatitis C Virus Infection: A Case Report","volume":"4","author":"Nayudu","year":"2011","journal-title":"Gastroenterol. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"457","DOI":"10.15403\/jgld.2014.1121.254.rah","article-title":"A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: A Pilot Study","volume":"25","author":"Rahimpour","year":"2016","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: Vancomycin or metronidazole in patients with primary sclerosing cholangitis\u2014A pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial","volume":"40","author":"Karvonen","year":"2004","journal-title":"Hepatology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","article-title":"Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis","volume":"24","author":"Tabibian","year":"2017","journal-title":"Am. J. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"814","DOI":"10.14309\/ajg.0000000000000604","article-title":"Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework","volume":"115","author":"Shah","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_113","first-page":"246","article-title":"Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis","volume":"15","author":"Hilscher","year":"2016","journal-title":"Ann. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/apt.12979","article-title":"Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis","volume":"40","author":"Rupp","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0039-1688501","article-title":"Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"39","author":"Shah","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1128\/AEM.72.3.1729-1738.2006","article-title":"Bile Salt Hydrolase Activity in Probiotics","volume":"72","author":"Begley","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1348-0421.2004.tb03526.x","article-title":"Comparison among Fecal Secondary Bile Acid Levels, Fecal Microbiota andClostridium scindensCell Numbers in Japanese","volume":"48","author":"Kitahara","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"eaax2358","DOI":"10.1126\/sciadv.aax2358","article-title":"Vancomycin relieves mycophenolate mofetil\u2013induced gastrointestinal toxicity by eliminating gut bacterial \u03b2-glucuronidase activity","volume":"5","author":"Taylor","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10875-012-9801-1","article-title":"Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis","volume":"33","author":"Abarbanel","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.31560","article-title":"Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/gutjnl-2018-316599","article-title":"Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis\u2013ulcerative colitis","volume":"68","author":"Tan","year":"2019","journal-title":"Gut"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/microbiolspec.BAD-0008-2017","article-title":"Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile","volume":"5","author":"Bakker","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ebiom.2019.05.066","article-title":"Fecal microbiota transplantation beyond Clostridioides difficile infections","volume":"44","author":"Wortelboer","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: Review and update","volume":"118","author":"Wang","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: Faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection","volume":"165","author":"Kelly","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","article-title":"Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection","volume":"156","author":"Hvas","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_128","first-page":"374","article-title":"Fecal Microbiota Transplantation for Inflammatory Bowel Disease","volume":"12","author":"Lopez","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"574533","DOI":"10.3389\/fphar.2020.574533","article-title":"Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update","volume":"11","author":"Tan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO3\u2212 umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jhep.2020.10.010","article-title":"Hepatobiliary acid-base homeostasis: Insights from analogous secretory epithelia","volume":"74","author":"Trampert","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.1840120523","article-title":"Hepatic injury induced by bile salts: Correlation between biochemical and morphological events","volume":"12","author":"Schmucker","year":"1990","journal-title":"Hepatology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000431071","article-title":"Biliary Mucosal Barrier and Microbiome","volume":"31","author":"Verdier","year":"2015","journal-title":"Visc. Med."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wu, T., Zhang, Z., Liu, B., Hou, D., Liang, Y., Zhang, J., and Shi, P. (2013). Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-669"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mbo3.218","article-title":"Characterization of the bile and gall bladder microbiota of healthy pigs","volume":"3","author":"Farina","year":"2014","journal-title":"Microbiology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","article-title":"Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation","volume":"141","author":"Steck","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s15010-012-0358-y","article-title":"Changing trend in bile microbiology and antibiotic susceptibilities: Over 12 years of experience","volume":"41","author":"Kwon","year":"2013","journal-title":"Infection"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2017.07.003","article-title":"Dysbiotic Proteobacteria expansion: A microbial signature of epithelial dysfunction","volume":"39","author":"Litvak","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury\u2014What is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00535-010-0204-x","article-title":"Bezafibrate for the treatment of primary sclerosing cholangitis","volume":"45","author":"Mizuno","year":"2010","journal-title":"J. Gastroenterol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jhbp.281","article-title":"Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis","volume":"22","author":"Mizuno","year":"2015","journal-title":"J. Hepato-Biliary-Pancreatic Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1872-034X.2007.00069.x","article-title":"Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice","volume":"37","author":"Shoda","year":"2007","journal-title":"Hepatol. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0024-3205(98)00249-5","article-title":"Bezafibrate has an antioxidant effect: Peroxisome proliferator-activated receptor \u03b1 is associated with Cu2+, Zn2+-superoxide dismutase in the liver","volume":"63","author":"Inoue","year":"1998","journal-title":"Life Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinre.2018.06.009","article-title":"Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French\u2013Spanish experience","volume":"42","author":"Lemoinne","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jso.2930530535","article-title":"Precancerous lesions of the biliary tree","volume":"53","author":"Callea","year":"1993","journal-title":"J. Surg. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0399-8320(04)95152-4","article-title":"Incidence of gastrointestinal cancers in France","volume":"28","author":"Bouvier","year":"2004","journal-title":"Gastroent\u00e9rologie Clinique et Biologique"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","article-title":"Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): A Comprehensive Review","volume":"58","author":"Song","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bbadis.2017.08.020","article-title":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","volume":"1864","author":"Chung","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000347206","article-title":"Primary Sclerosing Cholangitis and Cholangiocarcinoma: Pathogenesis and Modes of Diagnostics","volume":"31","author":"Ehlken","year":"2013","journal-title":"Dig. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/MIB.0b013e318281f49a","article-title":"Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma","volume":"19","author":"Timmer","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.27687","article-title":"IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism","volume":"61","author":"Yamada","year":"2015","journal-title":"Hepatology"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Saab, M., Mestivier, D., Sohrabi, M., Rodriguez, C., Khonsari, M.R., Faraji, A., and Sobhani, I. (2021). Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247798"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2015.06.018","article-title":"Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis","volume":"63","author":"Carpino","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"100226","DOI":"10.1016\/j.jhepr.2021.100226","article-title":"Cell of origin in biliary tract cancers and clinical implications","volume":"3","author":"Moeini","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0041-110792","article-title":"Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: Risk factors for biliary neoplasia","volume":"48","author":"Boyd","year":"2016","journal-title":"Endoscopy"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.freeradbiomed.2013.07.034","article-title":"Inflammation-related DNA damage and expression of CD133 and Oct3\/4 in cholangiocarcinoma patients with poor prognosis","volume":"65","author":"Thanan","year":"2013","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.humpath.2014.05.008","article-title":"Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma","volume":"45","author":"Kerr","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","article-title":"Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma","volume":"58","author":"Cadamuro","year":"2013","journal-title":"Hepatology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1038\/srep17450","article-title":"Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria","volume":"5","author":"Shen","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Ye, F., Shen, H., Li, Z., Meng, F., Li, L., Yang, J., Chen, Y., Bo, X., Zhang, X., and Ni, M. (2016). Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150519"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(00)80153-1","article-title":"Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis","volume":"33","author":"Hiramatsu","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hep.30852","article-title":"Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma","volume":"71","author":"Jia","year":"2020","journal-title":"Hepatology"},{"key":"ref_174","unstructured":"Jusakul, A., Khuntikeo, N., Haigh, W.G., Kuver, R., Ioannou, G.N., Loilome, W., Namwat, N., Bhudhisawasdi, V., Pugkhem, A., and Pairojkul, C. (2012). Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. Asian Pac. J. Cancer Prev., 13."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"178-e11","DOI":"10.1016\/j.cmi.2015.10.008","article-title":"Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma","volume":"22","author":"Guitron","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Gupta, A., Dhakan, D.B., Maji, A., Saxena, R., Prasoodanan, V.P.K., Mahajan, S., Pulikkan, J., Kurian, J., Gomez, A.M., and Scaria, J. (2019). Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India. MSystems, 4.","DOI":"10.1128\/mSystems.00438-19"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Van Nhieu, J.T., and Furet, J.-P. (2011). Microbial Dysbiosis in Colorectal Cancer (CRC) Patients. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016393"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-019-0712-8","article-title":"The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile","volume":"7","author":"Molinero","year":"2019","journal-title":"Microbiome"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI118878","article-title":"Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27\/human beta2 microglobulin transgenic rats","volume":"98","author":"Rath","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2017.09.022","article-title":"A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress Colitis","volume":"171","author":"Nanjundappa","year":"2017","journal-title":"Cell"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"042","DOI":"10.1055\/s-2006-933562","article-title":"Primary Sclerosing Cholangitis and Cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: Geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/IAI.00786-08","article-title":"Identification of a Bile-Induced Exopolysaccharide Required for Salmonella Biofilm Formation on Gallstone Surfaces","volume":"76","author":"Crawford","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1073\/pnas.1000862107","article-title":"Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage","volume":"107","author":"Crawford","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_185","first-page":"9","article-title":"Chronic and acute infection of the gall bladder by Salmonella Typhi: Understanding the carrier state","volume":"9","author":"Marshall","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/apt.12655","article-title":"Systematic review with meta-analysis: The relationship between chronicSalmonella typhicarrier status and gall-bladder cancer","volume":"39","author":"Nagaraja","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Sepe, L.P., Hartl, K., Iftekhar, A., Berger, H., Kumar, N., Goosmann, C., Chopra, S., Schmidt, S.C., Gurumurthy, R.K., and Meyer, T.F. (2020). Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallblader Cells. MBio., 11.","DOI":"10.1128\/mBio.01911-20"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrm.2016.100","article-title":"Subversion of host genome integrity by bacterial pathogens","volume":"17","author":"Chumduri","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.celrep.2015.05.030","article-title":"Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells","volume":"11","author":"Koeppel","year":"2015","journal-title":"Cell Rep."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"14944","DOI":"10.1073\/pnas.1100959108","article-title":"Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells","volume":"108","author":"Toller","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Hartl, K., and Sigal, M. (2020). Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207439"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000443349","article-title":"Coevolution between the Human Microbiota and the Epithelial Immune System","volume":"34","author":"Sigal","year":"2016","journal-title":"Dig. Dis."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Fa\u00efs, T., Delmas, J., Barnich, N., Bonnet, R., and Dalmasso, G. (2018). Colibactin: More Than a New Bacterial Toxin. Toxins, 10.","DOI":"10.3390\/toxins10040151"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","article-title":"Colibactin DNA-damage signature indicates mutational impact in colorectal cancer","volume":"26","author":"Berger","year":"2020","journal-title":"Nat. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli","volume":"580","author":"Puschhof","year":"2020","journal-title":"Nature"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21162-y","article-title":"Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells","volume":"12","author":"Iftekhar","year":"2021","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6975\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:26:13Z","timestamp":1760163973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":196,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22136975"],"URL":"https:\/\/doi.org\/10.3390\/ijms22136975","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]}}}